Organigram Global (OGI) Retained Earnings (2018 - 2026)
Organigram Global (OGI) posted quarterly Retained Earnings of -$430.0 million for Q1 2026, down 1.85% quarter-over-quarter from -$422.2 million in Q4 2025.
Organigram Global (OGI) Retained Earnings (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Retained Earnings for 9 consecutive years, with -$430.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings changed N/A year-over-year to -$430.0 million; the TTM figure through Mar 2026 stood at -$430.0 million (changed N/A YoY), while the FY2025 annual figure was -$422.2 million, changed N/A from the prior year.
- Retained Earnings slipped to -$430.0 million in Q1 2026 per OGI's latest filing, from -$422.2 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$46182.4 in Q3 2024 and bottomed at -$442.3 million in Q3 2025.
- Historically, Retained Earnings has averaged -$320.2 million across 5 years, with a median of -$411.9 million in 2023.
- Annual changes were most pronounced in 2024 — Retained Earnings surged 99.99% — and 2025, when it slumped 957673.27%.
- Organigram Global's Retained Earnings stood at -$225.1 million in 2022, then sank by 78.43% to -$401.7 million in 2023, then soared by 99.99% to -$46182.4 in 2024, then plunged by 914080.74% to -$422.2 million in 2025, then retreated by 1.85% to -$430.0 million in 2026.
- Business Quant data shows OGI's Retained Earnings at -$430.0 million in Q1 2026, -$422.2 million in Q4 2025, and -$442.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.75 Bn |
| 10 | Organigram Global | 150.66 Mn | 150.54 Mn | 28.97 Mn | -430.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -430.00 Mn |
| Dec 31, 2025 | -422.19 Mn |
| Sep 30, 2025 | -442.32 Mn |
| Sep 30, 2024 | -46,182.36 |
| Sep 30, 2023 | -401.70 Mn |
| Aug 31, 2022 | -225.13 Mn |
| Nov 30, 2021 | -276.95 Mn |
| Aug 31, 2021 | -275.64 Mn |
| May 31, 2021 | -249.67 Mn |
| Feb 28, 2021 | -245.67 Mn |
| Nov 30, 2020 | -179.28 Mn |
| Aug 31, 2020 | 37,208.64 |
| May 31, 2020 | -76.05 Mn |
| Feb 29, 2020 | -16.48 Mn |
| Aug 31, 2019 | -32,524.97 |
| May 31, 2019 | 34,000.00 |
| Aug 31, 2018 | 579,693.72 |